World Monitor Magazine April 2017 - Page 119

additional content isolated; repeated over and over with different variables in an incohesive pharmaceutical organization, they have a cascading effect that weakens the company’s performance. Exhibit 3: New pharma company operating model The critical team strategy To fix this broken system, pharmaceutical companies must address the shortcomings in their operating models. At its optimum, the front line of the pharmaceutical operating model would be composed of what Strategy& calls a critical team. The critical team is composed of four subteams that gather knowledge about and monitor issues pertaining to regulatory affairs, pricing and market access, government affairs, and medical affairs. These subteams act as cross-organizational threads to link together pivotal pharmaceutical functions that focus on evidence generation and management (R&D and pharmacovigilance